Ashish Kamat speaks with Shilpa Gupta about the JAVELIN trial and its impact on bladder cancer treatment. Dr. Gupta discusses how this study established avelumab maintenance therapy following platinum-based chemotherapy as a standard of care, improving both overall and progression-free survival. She highlights an abstract examining outcomes in diabetic patients, which shows maintenance avelumab…
Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income countries gain access?
Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income countries gain access?
DA Announces Commissioner’s National Priority Voucher Program (CNPVP)
Zealand Pharma said that its obesity candidate that uses a unique mechanism led to notable weight loss in an early trial.
At the 2025 UCSF-UCLA PSMA Conference, Amir Iravani compares FDA-approved PSMA PET agents (gallium-68 PSMA-11, DCFPyL, rhPSMA-7.3) for prostate cancer imaging. Dr. Iravani notes similar…
And more pharmaceutical daily news updates.
Nature Neuroscience – Some neurons act like body-proximity sensors. The authors show that these neurons reflect the value of contacting or avoiding objects. Together, these…
Patient-Specific 3D-VR Anatomical Modeling, DICOM Images, Patient-Specific 3D-VR Anatomical Modeling for Presurgical Planning Using DICOM Images and Open-Source Software, PSMA PET/CT, 99mTc-PSMA-I&S, salvage pelvic lymph…
At SLEEP 2025, Kancherla emphasized the importance of using pediatric criteria to manage OSA in adolescents, warning that adult standards may overlook key developmental factors.
At the 2025 UCSF-UCLA PSMA Conference, Michael Hofman presents the PRIMARY score for PSMA PET in prostate cancer diagnosis. He explains how PSMA PET complements…
